Frequently Asked Questions Is fever listed as a side effect of semaglutide in clinical trials
Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications
However, in February 2025, the FDA confirmed that shortages of both Ozempic and its weight loss counterpart, Wegovy, had been resolved, reducing the need for compounded alternatives
Additionally, the court will consider if the claims are preempted by federal law and determine whether GLP-1 drugs like Ozempic can cause the injuries in question, with decisions expected to impact the progression and potential settlement of these lawsuits
doi: 10.1177/0004563214557678 Summary Keywords carnitine, breast cancer, women, metabolites, risk assessment Citation Zhang J, Wu G, Zhu H, Yang F, Yang S, Vuong AM, Li J, Zhu D, Sun Y and Tao W (2022) Circulating Carnitine Levels and Breast Cancer: A Matched Retrospective Case-Control Study